Tarsus Pharmaceuticals, Inc.

TARS

$69.62

Name : Tarsus Pharmaceuticals, Inc.

Sector : Healthcare

Industry: Biotechnology

Mark. Cap: $2,938,734,848.00

EPSttm : -2.29

Tarsus Pharmaceuticals, Inc.

$69.62

1.75%

$1.19

Float Short %

19.77

Margin Of Safety %

Put/Call OI Ratio

0.27

EPS Next Q Diff

0.45

EPS Last/This Y

1.57

EPS This/Next Y

1.53

Price

68.44

Target Price

73.71

Analyst Recom

1.25

Performance Q

65.71

Relative Volume

0.98

Beta

0.81

Ticker: TARS

22 items of 1

Date	Symbol	Last	P/C OI	P/C Vol	Total OI
2025-09-08	TARS	56.65	0.09	0.10	1249
2025-09-09	TARS	56.48	0.08	0.00	1246
2025-09-10	TARS	54.57	0.08	0.50	1267
2025-09-11	TARS	51.88	0.08	0.26	1268
2025-09-12	TARS	49.33	0.08	0.02	1270
2025-09-15	TARS	49.74	0.07	0.05	1360
2025-09-16	TARS	50.53	0.07	0.00	1383
2025-09-17	TARS	51.69	0.073700543056633	0	1384
2025-09-18	TARS	54.04	0.07	0.05	1384
2025-09-19	TARS	55	0.07	0.00	1387
2025-09-22	TARS	55.65	0.13	0.00	804
2025-09-23	TARS	55.61	0.13	3.00	804
2025-09-24	TARS	55.21	0.13	0.00	817
2025-09-25	TARS	55.4	0.13	0.00	818
2025-09-26	TARS	56.26	0.13	0.67	823
2025-09-29	TARS	58.15	0.13	0.19	832
2025-09-30	TARS	59.19	0.13	16.00	850
2025-10-01	TARS	57.38	0.31	0.00	997
2025-10-02	TARS	58.74	0.31	0.00	988
2025-10-03	TARS	65.18	0.31	0.07	993
2025-10-06	TARS	67.81	0.31	0.02	992
2025-10-07	TARS	68.49	0.27	0.00	1065
Date	Symbol	Last	P/C OI	P/C Vol	Total OI

22 items 1 of 1

22 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2025-09-08	TARS	56.89	42.2	-	-1.50
2025-09-09	TARS	56.49	42.2	-	-1.50
2025-09-10	TARS	54.35	42.2	-	-1.50
2025-09-11	TARS	51.87	42.2	-	-1.50
2025-09-12	TARS	49.33	42.2	-	-1.50
2025-09-15	TARS	49.59	42.2	-	-1.50
2025-09-16	TARS	50.60	42.2	-	-1.50
2025-09-17	TARS	51.72	42.2	-	-1.50
2025-09-18	TARS	54.04	42.2	-	-1.50
2025-09-19	TARS	55.04	42.2	-	-1.50
2025-09-22	TARS	55.63	42.2	-	-1.50
2025-09-23	TARS	55.65	42.2	-	-1.50
2025-09-24	TARS	55.27	42.2	-	-1.50
2025-09-25	TARS	55.39	42.2	-	-1.50
2025-09-26	TARS	56.29	42.2	-	-1.50
2025-09-29	TARS	58.09	42.2	-	-1.50
2025-09-30	TARS	59.44	42.2	-	-1.50
2025-10-01	TARS	57.40	42.2	-	-1.50
2025-10-02	TARS	58.73	42.2	-	-1.50
2025-10-03	TARS	65.07	42.2	-	-1.50
2025-10-06	TARS	67.78	42.2	-	-1.50
2025-10-07	TARS	68.44	42.2	-	-1.50
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

22 items 1 of 1

22 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2025-09-08	TARS	-2.84	9.81	19.04
2025-09-09	TARS	-2.84	9.81	19.04
2025-09-10	TARS	-3.53	9.81	19.04
2025-09-11	TARS	-3.55	9.81	17.95
2025-09-12	TARS	-3.55	9.81	17.95
2025-09-15	TARS	-3.55	9.89	17.95
2025-09-16	TARS	-3.55	9.89	17.94
2025-09-17	TARS	-3.58	9.89	17.94
2025-09-18	TARS	-3.58	9.89	17.94
2025-09-19	TARS	-3.58	9.89	17.94
2025-09-22	TARS	-1.94	9.90	17.94
2025-09-23	TARS	-1.94	9.90	17.94
2025-09-24	TARS	-1.94	9.90	17.94
2025-09-25	TARS	-1.94	9.90	19.77
2025-09-26	TARS	-2.10	9.90	19.77
2025-09-29	TARS	-1.94	9.93	19.77
2025-09-30	TARS	-1.94	9.93	19.77
2025-10-01	TARS	-1.94	9.93	19.77
2025-10-02	TARS	-1.94	9.93	19.77
2025-10-03	TARS	-1.94	9.93	19.77
2025-10-06	TARS	-1.94	5.83	19.77
2025-10-07	TARS	-1.94	5.83	19.77
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

22 items 1 of 1

Last Quarter Act. EPS

-0.48

Avg. EPS Est. Current Quarter

-0.35

Avg. EPS Est. Next Quarter

-0.03

Insider Transactions

-1.94

Institutional Transactions

5.83

Beta

0.81

Average Sales Estimate Current Quarter

113

Average Sales Estimate Next Quarter

131

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

-0.7

Max Drawdown 5-Year %

Target Price

73.71

P/E

Forward P/E

70.29

PEG

P/S

9.77

P/B

8.68

P/Free Cash Flow

EPS

-2.33

Average EPS Est. Cur. Y

-1.5

EPS Next Y. (Est.)

0.03

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-31.13

Relative Volume

0.98

Return on Equity vs Sector %

-52.8

Return on Equity vs Industry %

-39.2

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Tarsus Pharmaceuticals, Inc.

Sector: Healthcare

Industry: Biotechnology

Employees: 323

Tarsus Pharmaceuticals, Inc., a commercial stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for eye care in the United States. The company's lead product candidate is XDEMVY, a novel therapeutic for the treatment of blepharitis caused by the infestation of Demodex mites, as well as to treat meibomian gland disease. It is also developing TP-04 for the treatment of Ocular Rosacea; TP-05 for potential Lyme disease prophylaxis; and community malaria reduction. In addition, the company develops lotilaner active pharmaceutical ingredient (API) to address diseases in human medicine, including eye care and infectious disease prevention. Tarsus Pharmaceuticals, Inc. was incorporated in 2016 and is headquartered in Irvine, California.

stock quote shares TARS – Tarsus Pharmaceuticals Inc Stock Price stock today

news today TARS – Tarsus Pharmaceuticals Inc stock forecast ,stock prediction 2023 2024 2025

marketwatch TARS – Tarsus Pharmaceuticals Inc yahoo finance google finance

stock history TARS – Tarsus Pharmaceuticals Inc invest stock market

stock prices TARS premarket after hours

ticker TARS fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Relative Volume

Beta

Ticker: TARS

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Last Quarter Act. EPS

Average EPS Est. Cur. Y